Marshall Wace, LLP Vor Biopharma Inc. Call Options Transaction History
Marshall Wace, LLP
- $77.3 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VOR
# of Institutions
57Shares Held
41.2MCall Options Held
9.3KPut Options Held
100-
Ra Capital Management, L.P. Boston, MA22.7MShares$23.2 Million0.22% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA6.36MShares$6.49 Million1.77% of portfolio
-
Hudson Bay Capital Management LP Greenwich, CT2.47MShares$2.52 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$1.99 Million0.0% of portfolio
-
Cowen And Company, LLC1.22MShares$1.25 Million0.02% of portfolio
About Vor Biopharma Inc.
- Ticker VOR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,056,300
- Market Cap $38.8M
- Description
- Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...